Wealth Enhancement Advisory Services LLC grew its stake in shares of HCA Healthcare Inc (NYSE:HCA) by 3.9% during the second quarter, Holdings Channel reports. The institutional investor owned 13,171 shares of the company’s stock after acquiring an additional 500 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in HCA Healthcare were worth $1,925,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in the business. Candriam Luxembourg S.C.A. increased its position in shares of HCA Healthcare by 13.7% in the second quarter. Candriam Luxembourg S.C.A. now owns 99,969 shares of the company’s stock worth $13,453,000 after acquiring an additional 12,036 shares in the last quarter. Redmond Asset Management LLC increased its position in shares of HCA Healthcare by 26.0% in the second quarter. Redmond Asset Management LLC now owns 14,672 shares of the company’s stock worth $1,983,000 after acquiring an additional 3,027 shares in the last quarter. DekaBank Deutsche Girozentrale increased its position in shares of HCA Healthcare by 67.8% in the second quarter. DekaBank Deutsche Girozentrale now owns 247,057 shares of the company’s stock worth $33,247,000 after acquiring an additional 99,843 shares in the last quarter. Westpac Banking Corp increased its position in shares of HCA Healthcare by 13.2% in the second quarter. Westpac Banking Corp now owns 353,407 shares of the company’s stock worth $47,770,000 after acquiring an additional 41,250 shares in the last quarter. Finally, CWM LLC increased its position in shares of HCA Healthcare by 176.1% in the second quarter. CWM LLC now owns 3,261 shares of the company’s stock worth $441,000 after acquiring an additional 2,080 shares in the last quarter. Institutional investors own 70.23% of the company’s stock.

HCA traded up $0.40 on Thursday, reaching $123.67. 36,359 shares of the company traded hands, compared to its average volume of 1,891,027. The business has a 50 day moving average price of $135.43. HCA Healthcare Inc has a 52-week low of $110.31 and a 52-week high of $147.42. The stock has a market cap of $42.90 billion, a P/E ratio of 12.64, a price-to-earnings-growth ratio of 1.08 and a beta of 0.85.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, July 30th. The company reported $2.21 EPS for the quarter, missing the Zacks’ consensus estimate of $2.49 by ($0.28). The company had revenue of $12.60 billion for the quarter, compared to analysts’ expectations of $12.61 billion. HCA Healthcare had a net margin of 7.46% and a negative return on equity of 135.90%. The business’s revenue for the quarter was up 9.3% on a year-over-year basis. During the same period in the previous year, the firm posted $2.29 earnings per share. Sell-side analysts predict that HCA Healthcare Inc will post 10.35 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Tuesday, September 3rd will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 1.29%. The ex-dividend date is Friday, August 30th. HCA Healthcare’s dividend payout ratio (DPR) is presently 16.38%.

In other news, major shareholder Patricia F. Elcan acquired 250 shares of HCA Healthcare stock in a transaction dated Tuesday, August 6th. The stock was acquired at an average cost of $124.10 per share, for a total transaction of $31,025.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Robert A. Waterman sold 33,786 shares of the business’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $134.98, for a total transaction of $4,560,434.28. Following the completion of the sale, the senior vice president now owns 279,551 shares of the company’s stock, valued at $37,733,793.98. The disclosure for this sale can be found here. 2.70% of the stock is owned by insiders.

Several research firms have recently weighed in on HCA. Barclays dropped their target price on shares of HCA Healthcare from $155.00 to $145.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 17th. Deutsche Bank lifted their target price on shares of HCA Healthcare from $160.00 to $165.00 and gave the stock a “buy” rating in a research report on Wednesday, May 1st. Jefferies Financial Group set a $158.00 price objective on shares of HCA Healthcare and gave the company a “buy” rating in a research report on Wednesday, April 17th. Raymond James raised shares of HCA Healthcare from a “market perform” rating to an “outperform” rating and boosted their price objective for the company from $115.00 to $135.00 in a research report on Tuesday, April 23rd. Finally, Mizuho set a $153.00 price objective on shares of HCA Healthcare and gave the company a “buy” rating in a research report on Wednesday, July 31st. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and seventeen have assigned a buy rating to the company’s stock. HCA Healthcare has a consensus rating of “Buy” and an average target price of $153.35.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Story: Calculate Your Return on Investment (ROI)

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.